People who purchased Chantix during a six-year period could be eligible to receive money from a $44 million class action settlement over allegations that the smoking-cessation drug contained an undisclosed nitrosamine, a substance that can cause cancer.
Pfizer has agreed to pay $44 million to settle a lawsuit, although the company denies the allegations and maintains that it did nothing wrong. Also, the court has not sided with Pfizer or the plaintiffs.
If the settlement receives final approval, eligible consumers who submit valid claims could receive a portion of the fund. The amount will depend on the number of eligible claims and how much…
Read the full article at MONEYTALKSNEWS.COM
